U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio
BUZZ-U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio July 13 (Reuters) - Wall Street's main indexes were on track to open lower on Monday as a fresh escalation between the U.S. and Iran in the Gulf pushed oil prices higher and unsettled investors, while chip stocks also came under pressure. .N
** Exxon Mobil Corp XOM.N:** Chevron Corp CVX.N:
** ConocoPhillips COP.N:
** Diamondback Energy Inc FANG.O:
BUZZ - US oil cos climb as renewed strikes threaten shipments through Hormuz nL4N43F0NG
** American Express Co AXP.N:
BUZZ - Rises after J.P. Morgan upgrades stock to 'overweight' nL6N43F0IR
** SK Hynix Inc SKHY.O:
** Western Digital Corp WDC.O:
** Seagate Technology Holdings PLC STX.O:
** Sandisk Corp SNDK.O:
BUZZ - US chipmakers fall on fresh US-Iran tensions, profit-taking in memory firms nL4N43F0P3
** Agenus Inc AGEN.O:
BUZZ - Secures up to $340 mln to advance colon cancer drug into late-stage study; shares jump nL4N43F0RV
** Walt Disney Co DIS.N:
BUZZ - Benchmark initiates coverage on Walt Disney with an 'outperform' rating nL6N43F0NA
** Apple Inc AAPL.O:
BUZZ - Citi raises Apple PT on pricing power, iPhone resilience and AI rollout nL4N43F0SK
** Kymera Therapeutics Inc KYMR.O:
BUZZ - RBC downgrades Kymera Therapeutics to 'sector perform,' raises PT nL4N43F0TI
** Deckers Outdoor Corp DECK.N:
BUZZ - Rises as Jefferies upgrades to 'buy', hikes PT citing Hoka's recovery nL6N43F0NY
** Ocugen Inc OCGN.O:
BUZZ - Rises on Mideast licensing deal for experimental blindness gene therapy nL4N43F0VJ
** Q32 Bio Inc QTTB.O:
BUZZ - Soars as hair-loss drug shows scalp hair regrowth in mid-stage study nL4N43F0VN
** Tonix Pharmaceuticals Holding Corp TNXP.O:
BUZZ - Rises on Medicare coverage expansion for chronic pain treatment nL4N43F0XH
** HF Sinclair Corp DINO.N:
** Marathon Petroleum Corp MPC.N:
** Phillips 66 PSX.N:
** Valero Energy Corp VLO.N:
BUZZ - Raymond James lifts PTs for US refiners, sees strong Q2 results nL4N43F0YO
** Niagen Bioscience Inc NAGE.O:
BUZZ - Rises after U.S., EU rare disease designations for drug candidate nL4N43F12L
** ANI Pharmaceuticals Inc ANIP.O:
BUZZ - Eye implant meets main goals in eye disease trial nL4N43F0V4
(Compiled by Rajarshi Roy and Shania S Thomas)
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer